HDIM
ELOS

Hanson & Doremus Investment Management’s Syneron Medical Ltd ELOS Stock Holding History

Hanson & Doremus Investment Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-475
Closed – – 469
2016
Q1 		$0 Buy
+475
New +$3.4K ﹤0.01% 477

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Hanson & Doremus Investment Management's ELOS Position: Q2 2016 in Review

Hanson & Doremus Investment Management sold out of Syneron Medical Ltd (ELOS) in Q2 2016, closing a stake of 475 shares.

Hanson & Doremus Investment Management first reported a position in ELOS in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 65 funds tracked by Wall St. Rank hold ELOS as of Q2 2016.

  • Hanson & Doremus Investment Management reported no remaining Syneron Medical Ltd position as of Q2 2016 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 475 Syneron Medical Ltd shares in Q2 2016.
  • Hanson & Doremus Investment Management first reported a position in Syneron Medical Ltd in Q1 2016 and held it in 1 quarter.
  • Hanson & Doremus Investment Management's Syneron Medical Ltd position peaked at $0 in Q1 2016.
  • 65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2016.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2016, filed 29 Jul 2016.